These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31056078)

  • 1. Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report.
    Joung S; Wei J; Nelson MD; Aldiwani H; Shufelt C; Tamarappoo B; Berman D; Thomson LEJ; Bairey Merz CN
    J Med Case Rep; 2019 May; 13(1):134. PubMed ID: 31056078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report.
    Narang N; Medvedofsky D; Dryer K; Shah SJ; Davidson CJ; Patel AR; Blair JEA
    ESC Heart Fail; 2017 Nov; 4(4):645-648. PubMed ID: 29154426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between longitudinal strain analysis and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Sucato V; Galassi AR; Novo S; Saladino A; Evola S; Novo G
    Microcirculation; 2020 Apr; 27(3):e12605. PubMed ID: 31889374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
    Elgendy IY; Pepine CJ
    Am J Med; 2019 Jun; 132(6):692-697. PubMed ID: 30684452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
    Kanagala P; Cheng ASH; Singh A; McAdam J; Marsh AM; Arnold JR; Squire IB; Ng LL; McCann GP
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):4. PubMed ID: 29321034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Microcirculation in Heart Failure with Preserved Systolic Function.
    Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M
    Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.
    Wei J; Nelson MD; Szczepaniak EW; Smith L; Mehta PK; Thomson LE; Berman DS; Li D; Bairey Merz CN; Szczepaniak LS
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H14-9. PubMed ID: 26519031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
    Kristensen SL; Mogensen UM; Jhund PS; Petrie MC; Preiss D; Win S; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Gottdiener JS; Carson PE; McMurray JJ
    Circulation; 2017 Feb; 135(8):724-735. PubMed ID: 28052977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
    Shah AM; Claggett B; Sweitzer NK; Shah SJ; Anand IS; O'Meara E; Desai AS; Heitner JF; Li G; Fang J; Rouleau J; Zile MR; Markov V; Ryabov V; Reis G; Assmann SF; McKinlay SM; Pitt B; Pfeffer MA; Solomon SD
    Circ Heart Fail; 2014 Sep; 7(5):740-51. PubMed ID: 25122186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction.
    Gurwitz JH; Magid DJ; Smith DH; Goldberg RJ; McManus DD; Allen LA; Saczynski JS; Thorp ML; Hsu G; Sung SH; Go AS
    Am J Med; 2013 May; 126(5):393-400. PubMed ID: 23499328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
    PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.
    Shah AM; Shah SJ; Anand IS; Sweitzer NK; O'Meara E; Heitner JF; Sopko G; Li G; Assmann SF; McKinlay SM; Pitt B; Pfeffer MA; Solomon SD;
    Circ Heart Fail; 2014 Jan; 7(1):104-15. PubMed ID: 24249049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.
    Paolisso P; Gallinoro E; Belmonte M; Bertolone DT; Bermpeis K; De Colle C; Shumkova M; Leone A; Caglioni S; Esposito G; Fabbricatore D; Moya A; Delrue L; Penicka M; De Bruyne B; Barbato E; Bartunek J; Vanderheyden M
    Circ Heart Fail; 2024 Jan; 17(1):e010805. PubMed ID: 38108151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of biomarkers for the presence and progression of left ventricular diastolic dysfunction and HEart faiLure with Preserved ejection Fraction in patients at risk for cardiovascular disease: rationale and design of the HELPFul case-cohort study in a Dutch cardiology outpatient clinic.
    Valstar GB; Bots SH; Groepenhoff F; Gohar A; Rutten FH; Leiner T; Cramer MJM; Teske AJ; Suciadi LP; Menken R; Pasterkamp G; Asselbergs FW; Hofstra L; Bots ML; den Ruijter HM
    BMJ Open; 2019 Jun; 9(6):e028408. PubMed ID: 31171553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.